Retraction
LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis
Paper Information
Record ID:
41599
Author(s):
Publication Date:
October 12, 2020
Retraction Date:
December 15, 2022
(2.9 years years ago)
Subjects:
Institution:
Department of Gynecology, The First People’s Hospital of Lianyungang, Lianyungang 222000, Peoples’ Republic of ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (26)
26
Total Citations5
Post-Retraction(19.2%)
21
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
0
After 2+ years
516
Days since retraction (latest)
Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis
Xueyan Zhang, Bo-Chi Zhu, Miao He et al. (4 authors)
Journal of Ovarian Research
Open Access
Published: May 2024
1 citation
1 citation
516 days after retraction
LINC01980 induced by TGF-beta promotes hepatocellular carcinoma metastasis via miR-376b-5p/E2F5 axis
Jiaqi Sheng, Yiming Luo, Enjun Lv et al. (10 authors)
Cellular Signalling
Published: Oct 2023
3 citations
3 citations
299 days after retraction
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
Aryan Rezaee, Sara Ahmadpour, Ameneh Jafari et al. (10 authors)
Frontiers in Oncology
Open Access
Published: Oct 2023
4 citations
4 citations
292 days after retraction
Transcription factor c-fos induces the development of premature ovarian insufficiency by regulating MALAT1/miR-22-3p/STAT1 network
Ting Qiu, Jie Zhou, Bing Ji et al. (6 authors)
Journal of Ovarian Research
Open Access
Published: Jul 2023
4 citations
4 citations
218 days after retraction
A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle
Hongli Li, Lulu Dong, Min-Jie Jin et al. (9 authors)
Molecules
Open Access
Published: Jan 2023
12 citations
12 citations
39 days after retraction
Identification and validation of a novel long non-coding RNA (LINC01465) in ovarian cancer
Shika Hanif Malgundkar, Nada Abdullah Hassan, Hala Al Badi et al. (12 authors)
Human Cell
Published: Dec 2022
8 citations
8 citations
2 days before retraction
<scp>METTL3</scp>‐mediated <scp>m6A</scp> modification of lnc <scp>RNA RHPN1‐AS1</scp> enhances cisplatin resistance in ovarian cancer by activating <scp>PI3K</scp>/<scp>AKT</scp> pathway
Shoubin Cui
Journal of Clinical Laboratory Analysis
Open Access
Published: Nov 2022
23 citations
23 citations
39 days before retraction
FAM201A Promotes Cervical Cancer Progression and Metastasis through miR-1271-5p/Flotillin-1 Axis Targeting-Induced Wnt/β-Catenin Pathway
Yuehong Wang, Zhilian Wang, Keyan Cheng et al. (4 authors)
Journal of Oncology
Open Access
Published: Oct 2022
7 citations
7 citations
73 days before retraction
Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway
Jia Li, Zhidong Zhang, Yuanjing Hu et al. (5 authors)
Anti-Cancer Drugs
Published: Sep 2022
4 citations
4 citations
92 days before retraction
Functional roles of long noncoding RNA MALAT1 in gynecologic cancers
Maryam Farzaneh, Sajad Najafi, Mahrokh Abouali Gale Dari et al. (7 authors)
Clinical & Translational Oncology
Published: Aug 2022
7 citations
7 citations
107 days before retraction
Exosomes Derived from Tumor Cells Initiate Breast Cancer Cell Metastasis and Chemoresistance through a MALAT1-Dependent Mechanism
Shuang Tao, Zhengyang Bai, Yaobang Liu et al. (7 authors)
Journal of Oncology
Open Access
Published: Jun 2022
16 citations
16 citations
168 days before retraction
RETRACTED ARTICLE: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
Xingguang Liu, Tengda Zhao, Zhe Yuan et al. (4 authors)
Cell Death Discovery
Open Access
Published: Apr 2022
6 citations
6 citations
239 days before retraction
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity
Mahmood Khaksary Mahabady, Sepideh Mirzaei, Hamidreza Saebfar et al. (16 authors)
Journal of Cellular Physiology
Published: Apr 2022
21 citations
21 citations
241 days before retraction
Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a
Chenxiao Lin, Meiyun Zheng, Youlin Yang et al. (7 authors)
Bioengineered
Open Access
Published: Apr 2022
18 citations
18 citations
258 days before retraction
Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis
Lu Zhou, Juan Ye, Fengyun Wen et al. (4 authors)
Disease Markers
Open Access
Published: Mar 2022
7 citations
7 citations
276 days before retraction
SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
Wujiang Gao, Lu Chen, Lin Li et al. (14 authors)
Oncogenesis
Open Access
Published: Mar 2022
31 citations
31 citations
280 days before retraction
JMJD2C-mediated long non-coding RNA MALAT1/microRNA-503-5p/SEPT2 axis worsens non-small cell lung cancer
Jun Zhang, Mingliang Wang, Jiashun Wang et al. (4 authors)
Cell Death and Disease
Open Access
Published: Jan 2022
11 citations
11 citations
330 days before retraction
Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer
Maritza P. Garrido, Allison N. Fredes, Lorena Lobos‐González et al. (6 authors)
Biomedicines
Open Access
Published: Dec 2021
28 citations
28 citations
349 days before retraction
Multiple function of lncRNA MALAT1 in cancer occurrence and progression
Faezeh Malakoti, Niloufar Targhazeh, Haniye Karimzadeh et al. (7 authors)
Chemical Biology & Drug Design
Published: Dec 2021
29 citations
29 citations
363 days before retraction
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady et al. (14 authors)
Phytotherapy Research
Published: Oct 2021
162 citations
162 citations
416 days before retraction
(In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers
Maja Sabol, Jean Calleja‐Agius, Riccardo Di Fiore et al. (7 authors)
Cancers
Open Access
Published: Oct 2021
7 citations
7 citations
432 days before retraction
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
Hua Lan, Jing Yuan, Da Zeng et al. (8 authors)
Frontiers in Genetics
Open Access
Published: Aug 2021
15 citations
15 citations
482 days before retraction
HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
Yujie Dong, Wei Feng, Li Yan
Frontiers in Cell and Developmental Biology
Open Access
Published: Jul 2021
19 citations
19 citations
521 days before retraction
lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell
Yongye Huang, Ziyan Zhou, Jin Zhang et al. (12 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Jun 2021
43 citations
43 citations
539 days before retraction
The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression
Kai Su, Nannan Wang, Qianqian Shao et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Feb 2021
104 citations
104 citations
667 days before retraction
Downregulation of long non-coding RNA UCA1 represses tumorigenesis and metastasis of osteosarcoma via miR-513b-5p/E2F5 axis
Zhixiang Zhang, Xuejian Wu, Qicai Han et al. (4 authors)
Anti-Cancer Drugs
Published: Feb 2021
14 citations
14 citations
668 days before retraction
Quick Stats
Total Citations:
26
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025